<DOC>
	<DOCNO>NCT01294267</DOCNO>
	<brief_summary>The purpose research study evaluate safety feasibility Impella 2.5 Circulatory Support System use map ablation ventricular tachycardia set Ventricular dysfunction .</brief_summary>
	<brief_title>Percutaneous Hemodynamic Support With Impella 2.5 During Scar-related Ventricular Tachycardia Ablation</brief_title>
	<detailed_description>The Impella 2.5 percutaneous heart pump use provide partial circulatory support - . The Impella 2.5 approve US Food Drug Administration test see help keep patient 's blood pressure stable cardiac ablation procedure . The Impella 2.5 Circulatory Support System work place small pump leave pump chamber heart help heart circulate blood throughout body . The Impella 2.5 Circulatory Support system remove heart longer need help pump action time completion heart procedure several day post procedure determine physician .</detailed_description>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<criteria>male female age 18 90 year catheter ablation ventricular tachycardia Left Ventricular ejection fraction less equal 40 % hypertrophic cardiomyopathy Any reversible cause VT [ electrolyte derangement , medication relate itc ] Evidence active , ongoing cardiac ischemia cause VT Patients experience cerebral ischemic event include TIA precede one month Mural thrombus leave Ventricle Presence mechanical aortic valve Severe Aortic Stenosis [ orifice area 2.0 cm2 less ] moderate severe aortic insufficiency Severe abnormalities aorta would preclude Impella insertion , include aneurysms extreme tortuosity calcification Liver dysfunction markedly abnormal coagulation parameter [ define platelet count less equal 50,000/ul ] Any condition result contraindication anticoagulation [ eg GI bleed ] Women know pregnant positive BHCG test 7 day prior procedure Patients whose life expectancy le one year Mental Impairment preclude patient family provide informed consent complete appropriate follow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Ventricular Tachycardia</keyword>
	<keyword>Radio Frequency Ablation</keyword>
	<keyword>Percutaneous Left Ventricular Assist Device</keyword>
	<keyword>Hemodynamic Management</keyword>
	<keyword>Interventional Cardiac Procedure</keyword>
	<keyword>Mechanical Cardiac Assistance</keyword>
	<keyword>Intra-Aortic Balloon Pump</keyword>
	<keyword>Coronary Intervention</keyword>
	<keyword>Impella 2.5</keyword>
	<keyword>Circulation Support system</keyword>
</DOC>